Report ID: SQMIG35D2005
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Animal Health Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Animal Health industry players.
The growing occurrence of infectious and zoonotic diseases is a major force accelerating the global animal health market. Disease outbreaks such as avian influenza, African swine fever, and foot-and-mouth disease severely disrupt livestock productivity, trade flows, and food security. As a direct consequence, governments tighten surveillance systems, enforce vaccination mandates, and strengthen biosecurity frameworks. Farmers, aiming to avoid economic losses, increase spending on preventive vaccines, diagnostics, and herd monitoring technologies. This cause-and-effect chain shifts the industry from emergency response toward preventive healthcare models, driving consistent demand for veterinary pharmaceuticals, biologics, and disease management solutions worldwide.
According to SkyQuest Technology “Global Animal Health Market” By Animal Type (Production Animals, Companion Animals), By Product (Biologics, Pharmaceuticals), By End Use, By Region - Industry Forecast 2026-2033,” Global animal health market is projected to grow at a CAGR of over 7.3% by 2033, on account of urgent need for automating quantified data. The steady rise in companion animal ownership is a powerful supporting factor behind animal health market expansion. Urbanization, smaller family structures, and changing lifestyles are prompting more households to adopt pets for companionship.
|
Company |
Est. Year |
Headquarters |
Revenue |
Key Services |
|
Zoetis Inc. |
1952 |
Parsippany, New Jersey |
USD 9.25 Billion (2024) |
Veterinary pharmaceuticals, vaccines, diagnostics, genetic tests and pet/livestock health solutions |
|
Elanco Animal Health Inc. |
1954 |
Greenfield, Indiana |
USD 4.44 Billion (2024) |
Animal medicines, biologics, feed additives, parasiticides and digital livestock health solutions |
|
Merck & Co., Inc. |
1891 |
Rahway, New Jersey |
USD 5.9 Billion (2024) |
Vaccines, medicines, parasiticides, digital monitoring and identification technologies |
|
Boehringer Ingelheim Animal Health |
1885 |
Ingelheim am Rhein, Germany |
USD 4.94 Billion (2024) |
Vaccines, parasiticides and preventive animal healthcare products |
|
Ceva Santé Animale |
1999 |
Libourne, France |
USD 1.84 Billion (2024) |
Veterinary pharmaceuticals, vaccines, reproductive and behaviour health solutions, hatchery services and equipment |
|
Virbac |
1968 |
Carros, France |
USD 1.45 Billion (2024) |
Veterinary vaccines, antibiotics, parasiticides, dermatology products and nutritional supplements for livestock and companion animals. |
|
Vetoquinol |
1933 |
Lure, France |
USD 593 Million (2024) |
medications for pain, inflammation, dermatology, anti-parasite treatment and general wellbeing for pets and farm animals |
|
IDEXX Laboratories, Inc. |
1983 |
Westbrook, Maine |
USD 3.9 Billion (2024) |
Diagnostic products, veterinary testing systems, digital practice management and water/dairy testing solutions |
|
Phibro Animal Health Corporation |
1946 |
Teaneck, New Jersey |
NA |
Animal health solutions including vaccines, medicated feed additives, nutrition and mineral products for livestock and other species |
|
Neogen Corporation |
1982 |
Lansing, Michigan |
NA |
Diagnostic kits and safety testing solutions for livestock and food production |
Zoetis Inc. is a global leader in the animal health market, dedicated to advancing care for animals by discovering, developing, manufacturing, and commercializing a diverse portfolio of vaccines, medicines, diagnostics, and innovative technologies for both companion animals and livestock. Founded in 1952 and headquartered in Parsippany, New Jersey, USA, Zoetis serves customers in over 100 countries, supporting veterinarians, pet owners, and livestock producers with cutting-edge solutions that help predict, prevent, detect, and treat diseases. Its scale, innovation focus, and science-driven approach firmly position it as a market frontrunner worldwide.
Elanco Animal Health Inc. is a global leader in animal health, focused on innovating, developing, manufacturing, and delivering products and services to prevent and treat diseases in both farm animals and pets around the world. Headquartered in Greenfield, Indiana, USA, and formally established in 1954, the company offers a broad portfolio that includes parasiticides, vaccines, therapeutics, and medicated feed additives for multiple species. Elanco’s solutions help farmers, veterinarians, and pet owners improve animal welfare, enhance productivity, and address evolving health challenges in more than 90 countries.
Merck & Co., Inc. (through its Merck Animal Health division) is a global leader in veterinary medicines, vaccines, and animal health technologies, dedicated to preserving and improving the health, well-being, and performance of both companion animals and livestock worldwide. Headquartered in Rahway, New Jersey, USA and established in 1891, Merck leverages deep scientific research to develop and deliver a broad portfolio of veterinary pharmaceuticals, parasiticides, disease-preventive vaccines, and connected health solutions that support veterinarians, farmers, and pet owners across more than 150 markets. Its animal health business strengthens food safety and animal welfare through innovation and global reach.
Boehringer Ingelheim Animal Health is a leading global animal health business dedicated to improving the well-being and productivity of pets and livestock through vaccines, parasiticides, therapeutics, diagnostics, and disease-management solutions. Founded as part of Boehringer Ingelheim in 1885 and headquartered in Ingelheim am Rhein, Germany, the division leverages deep scientific research to prevent and treat infectious and parasitic diseases across multiple species worldwide. Its innovative, preventive approach supports veterinarians, farmers, and pet owners in more than 150 countries, reinforcing animal welfare and food safety with cutting-edge health products and services.
Ceva Santé Animale is a leading global animal health company focused on researching, developing, producing, and marketing veterinary pharmaceutical products and vaccines for companion animals, poultry, swine, and ruminants. Founded in 1999 and headquartered in Libourne, France, it has grown to be among the top five animal health firms worldwide, with operations in over 110 countries and thousands of employees. Ceva’s portfolio extends from preventive vaccines and therapeutic pharmaceuticals to animal welfare products and related services, supporting veterinarians, farmers, and pet owners in enhancing animal health and productivity globally.
Virbac is a global animal health company dedicated to improving the health and well-being of companion animals and livestock through a comprehensive range of vaccines, pharmaceuticals, parasiticides, dermatology products, and nutritional supplements. Founded in 1968 and headquartered in Carros, France, Virbac operates in more than 100 countries, partnering with veterinarians and animal caregivers to prevent and treat disease. Its science-driven approach emphasizes innovative solutions that enhance animal welfare, support disease control, and improve productivity across species, making it a key player in the worldwide animal health market.
Vetoquinol is a global animal health company focused on improving animal welfare and productivity through the research, development, production, and marketing of veterinary drugs and related health products for both companion animals (dogs and cats) and livestock (cattle and pigs). Founded in 1933 and headquartered in Lure, France, it operates in more than 90 countries with products addressing pain and inflammation, dermatology, parasitic control, reproduction, and general health needs. Vetoquinol also offers non-medicinal products, diagnostics, digital applications, and services, reinforcing its commitment to animal health and veterinary support worldwide.
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, software, and animal health testing solutions, focused on helping veterinarians and animal caregivers make confident clinical decisions and improve animal well-being. Founded in 1983 and headquartered in Westbrook, Maine, USA, IDEXX designs, manufactures, and distributes in-clinic diagnostic instruments and reagents, reference laboratory testing services, practice management software, livestock and poultry disease diagnostics, and water and dairy quality testing products to customers in over 175 countries. Its innovations support animal health, food safety, and veterinary practice efficiency worldwide.
Phibro Animal Health Corporation is a global animal health and nutrition company dedicated to enhancing animal performance, disease prevention, and overall health through a broad range of vaccines, medicated feed additives, specialty minerals, and nutritional solutions for livestock and poultry. Founded in 1946 and headquartered in Teaneck, New Jersey, USA, Phibro serves customers in more than 70 countries, helping producers improve feed efficiency, disease resistance, and productivity. Its science-driven product portfolio supports sustainable animal agriculture and addresses key industry challenges worldwide.
Neogen Corporation is a global provider of animal health and food safety solutions, offering a broad range of diagnostic test kits, veterinary instruments, pharmaceuticals, vaccines, and advanced genomics services that help detect pathogens, toxins, allergens, and drug residues in animals and food production systems. Founded in 1982 and headquartered in Lansing, Michigan, USA, the company serves veterinarians, livestock producers, and the food industry across numerous countries. By combining scientific innovation with comprehensive testing and animal safety products, Neogen enhances animal welfare, food security, and agricultural productivity worldwide.
The global animal health market is evolving from reactive treatment toward preventive, technology-enabled care driven by rising disease threats and growing companion animal ownership. Strengthened biosecurity policies, routine vaccination programs, and increased spending on diagnostics and monitoring tools are reshaping how animal health is managed worldwide. At the same time, pet humanization is expanding demand for advanced veterinary services and premium therapeutics. Supported by innovation from leading multinational companies and rising awareness of animal welfare and food safety, the industry is positioned for sustained growth, playing a vital role in protecting livestock productivity, public health, and global food security.
REQUEST FOR SAMPLE
Global Animal Health Market size was valued at USD 67.92 Billion in 2024 poised to grow from USD 72.88 Billion in 2025 to USD 128.05 Billion by 2033, growing at a CAGR of 7.3% in the forecast period (2026–2033).
The global animal health market outlook is highly competitive, with key players including Zoetis, Elanco, Merck Animal Health, Boehringer Ingelheim, and Virbac. These companies focus on strategies like product innovation, mergers and acquisitions, and expanding diagnostic capabilities. For instance, Zoetis invests heavily in R&D for companion animal biologics, while Elanco enhances its livestock portfolio through strategic acquisitions, strengthening its global footprint and broadening its animal health product offerings. 'Zoetis Inc. (USA)', 'Merck Animal Health (MSD Animal Health) (USA)', 'Elanco Animal Health Incorporated (USA)', 'Boehringer Ingelheim Animal Health (Germany)', 'Bayer Animal Health (Germany)', 'Virbac (France)', 'Ceva Santé Animale (France)', 'Vetoquinol (France)', 'Dechra Pharmaceuticals (UK)', 'Phibro Animal Health Corporation (USA)', 'Heska Corporation (USA)', 'IDEXX Laboratories, Inc. (USA)', 'Ourofino Saúde Animal (Brazil)', 'Zydus Animal Health and Investments Ltd. (India)', 'China Animal Husbandry Industry Co., Ltd. (China)'
Growing global pet ownership, especially of dogs and cats, is significantly boosting the global animal health market growth. Increased human-animal bonding drives higher spending on preventive care, diagnostics, and pharmaceuticals. This trend supports growth in companion animal healthcare services, encouraging innovation and investment across the veterinary pharmaceutical and diagnostics industries.
Rise of Preventive Pet Healthcare: Growing awareness among pet owners is fueling demand for preventive care, including vaccinations, routine checkups, and wellness products. This trend is reshaping veterinary services, with increased spending on companion animal wellness, thereby driving innovation in diagnostics, digital tools, and early intervention therapies.
Why is the North American Animal Health Market Considered Advanced?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2005
sales@skyquestt.com
USA +1 351-333-4748